Moreover, mid-regional proadrenomedullin (MR-proADM) and liver-type fatty acid-binding protein (L-FABP) have emerged as biomarkers able to predict the decline of renal function and morbidity in patients with HF [99]. Here, FABP1 is linked to hydrops fetalis.